知镜 Cognispect · 医学文献与研究工作台

Multiparametric MRI radiomics improves growth risk stratification beyond conventional imaging in incidental asymptomatic meningiomas

Mei N, Chen Y, Yin B, et al.
European journal of radiology · 2026-09-23 · PMID 42804813

文献摘要

Objective Incidental asymptomatic meningiomas are increasingly detected, yet predicting growth remains challenging. We aimed to determine whether a combined model integrating multiparametric MRI radiomics with clinical and semantic features improves growth risk stratification beyond conventional imaging in incidental asymptomatic meningiomas. Methods This retrospective study included 519 patients from Institution A (training, n = 416; internal validation, n = 103) and 83 patients from two external institutions (external validation). Tumor growth was defined by volumetric criteria. Radiomic features were extracted from contrast-enhanced T1-weighted imaging (T1C), T2-weighted fluid-attenuated inversion recovery (T2-FLAIR), and apparent diffusion coefficient (ADC) sequences. A random survival forest (RSF) model combining all features was developed and validated. A simplified scoring system was derived from the most important features. Results The combined RSF model demonstrated excellent discrimination, with C-indices of 0.901 (training), 0.837 (internal validation), and 0.813 (external validation), significantly outperforming a clinical-only model (ΔC-index up to 0.223). 9-point radiomics-based scoring system (cutoff = 5 points) stratified patients into high- and low-risk groups. The top predictive features included T1C (GLSZM GrayLevelNonUniformity, wavelet GLCM autocorrelation), T2-FLAIR and ADC texture features, and surface area. Conclusion Multiparametric MRI radiomics improves growth risk stratification beyond conventional imaging. The simplified scoring system may support personalized surveillance while reducing unnecessary interventions, although prospective validation is required before clinical implementation.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。